GSK Licenses SGLT2-inhibitor from Kissei
By Business Review Editor
Pharma Deals Review: Vol 2002 Issue 30 (Table of Contents)
Published: 2 Nov-2002
DOI: 10.3833/pdr.v2002.i30.979 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
GSK entered into an exclusive worldwide licensing agreement with Kissei for SGLT2-inhibitors for relieving hyperglycaemia...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS